Substantial evidence suggests that catechol estrogen-3,4-quinones, react with DNA to form predominantly the depurinating adducts, 4-hydroxyestrone(estradiol)-1-N3Ade [4-OHE 1 (E 2 )-1-N3Ade] and 4-OHE 1 (E 2 )-1-N7Gua. Apurinic sites resulting from these adducts generate critical mutations that can initiate cancer. The paradigm of cancer initiation is based on imbalancing estrogen metabolism between activating pathways that lead to estrogen-DNA adducts and deactivating pathways that lead to estrogen metabolites and conjugates. This balance can be improved to minimize formation of adducts by using antioxidants, such as resveratrol (Resv) and N-acetylcysteine (NAcCys).
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Introduction
Substantial evidence from experiments on estrogen metabolism [1] [2] [3] , formation of DNA adducts [4] [5] [6] [7] [8] , mutagenicity [9] [10] [11] [12] [13] , cell transformation [14] [15] [16] and carcinogenicity [17] [18] [19] [20] suggests that certain estrogen metabolites, particularly catechol estrogen-3,4-quinones, react with DNA to form predominantly the depurinating adducts, 4-hydroxyestrone(estradiol)-1-N3Ade [4-OHE 1 (E 2 )-1-N3Ade] and 4-OHE 1 (E 2 )-1-N7Gua [4] [5] [6] (Fig. 1) . Apurinic sites resulting from formation of these adducts can undergo error-prone repair to generate critical mutations that can initiate cancer [9] [10] [11] 21] . This paradigm of cancer initiation is based on disruption of the homeostatic balance in estrogen metabolism. The balance is between activating pathways that can lead to estrogen-DNA adducts and deactivating pathways that lead to estrogen metabolites and conjugates ( Fig. 1 ). This hypothesis has been supported by results obtained in women, in which the level of estrogen-DNA adducts in urine from healthy women is low and the levels of estrogen conjugates are high. In contrast, higher levels of adducts and lower levels of conjugates are present in the urine of women with breast cancer or at high risk for the disease [7, 22] .
The oxidation of catechol estrogens to quinones can be reduced by the intervention of phase II enzymes. For example, catechol-O-methyltransferase (COMT)
catalyzes the methylation of catechol estrogens, thereby preventing their conversion to estrogen semiquinones and quinones ( Fig. 1 ). In fact, we have obtained increased formation of estrogen-DNA adducts when the activity of COMT was inhibited [23, 24] .
A second conjugation that prevents the reaction of catechol estrogen quinones with DNA is provided by the cellular antioxidant glutathione (GSH), either non-enzymatically or,
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4 more efficiently, with the catalytic action of glutathione-S-transferase. Other phase II enzymes, such as quinone reductase (NQO1 and NQO2) are also involved in the detoxification of the quinones by their reduction to catechol estrogens [25] [26] [27] (Fig. 1) .
The balance between activating and deactivating pathways leading to estrogen-DNA adducts or estrogen conjugates, respectively, can be further improved to minimize formation of adducts and maximize formation of conjugates. The use of specific antioxidant compounds can potentially achieve this improved balance of estrogen homeostasis. In a preliminary in vitro study, we tested several antioxidants, cysteine, Nacetylcysteine (NAcCys), GSH, melatonin, resveratrol (Resv) and reduced lipoic acid [28] . The best inhibitors of formation of depurinating estrogen-DNA adducts were Resv and NAcCys.
NAcCys is an acetylamino thiol. Its hydrolytic product, cysteine, is one of the three amino acids present in the intracellular antioxidant GSH [29] . Changes in GSH homeostasis have been implicated in the etiology and progression of a variety of human diseases, including cancer [30] . NAcCys has been used as a mucolytic drug [31] and as an antidote for paracetamol poisoning [32] . Later it was shown to have antioxidant and anticoagulant properties [33] [34] [35] [36] .
Resv (3,5,4′-trihydroxystilbene) is a natural antioxidant present in grapes and many other plants [37] and has anticarcinogenic effects in diverse in vitro and in vivo systems [38, 39] .
Using the human breast epithelial cell line MCF-10F (estrogen receptor-α negative and aryl hydrocarbon receptor positive), we have investigated the effects of Resv [16, 40] and NAcCys [41] on estrogen metabolism and formation of estrogen-DNA
adducts. In the present study, we have compared the ability of Resv and NAcCys to block formation of estrogen-DNA adducts, using the two compounds individually and mixed together.
Materials and Methods
Chemicals and reagents. 4-OHE 2 and all standards were synthesized in our laboratory, as previously described [4, 5, 42, 43] . All other chemicals were purchased from Sigma (St.
Louis, MO) and used without further purification.
Cell culture and treatment. MCF-10F cells were obtained from the ATCC (Rockville, MD), and cultured in DMEM and Ham's F12 media (Mediatech, Inc) with 20 ng/ml epidermal growth factor, 0.01 mg/ml insulin, 500 ng/ml hydrocortisone, 5% horse serum and 100 µg/ml penicillin/streptomycin mixture. Estrogen-free medium was prepared in phenol red-free DME/F12 medium with charcoal-stripped FBS (HyClone, Logan, UT).
Cell viability was determined by the MTT [3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltrazolium bromide, Sigma] assay [44] .
Cytotoxicity Assay. Cells were seeded at a density of 3000 cells/well in 96-well plates. Once the media were removed from five flasks, each flask was incubated at 37 °C with 1 ml of trypsin. After 10 min, 10 ml of double serum media was used to combine the cells from all five flasks. Cell numbers were estimated by using a Coulter counter (Beckman Coulter, Inc., USA).
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Analysis of estrogen-DNA adducts. Following the treatments, media were harvested, supplemented with 2 mM ascorbic acid (to prevent possible decomposition of the compounds) and processed immediately. Sample preparation and analysis by HPLC with electrochemical detection (HPLC-ECD) was carried out as follows:
Sample preparation. Culture media from five flasks (50 ml) were processed by passage through C8 Certify II cartridges (Varian, Harbor City, CA), which were equilibrated by sequentially passing 1 ml of methanol, distilled water, and potassium phosphate buffer (100 mM, pH 8) through them. The harvested media (50 ml) were adjusted to pH 8.0 and passed through these cartridges. The retained analytes in the cartridges were washed with the above phosphate buffer, eluted with methanol:acetonitrile:water:trifluoroacetic acid (8:1:1:0.1), and processed as described previously [15] .
HPLC-ECD.
Analyses of all samples were conducted on an HPLC system equipped with dual ESA Model 580 solvent delivery modules, an ESA Model 540 auto-sampler and a 12-channel CoulArray electrochemical detector (ESA, Chelmsford, MA) using the method previously described [15] . Three-point calibration curves were run for each standard. Triplicate samples were analyzed for each data point. The analytes were identified by their retention time and peak height ratios between the dominant peak and the peaks in the two adjacent channels. The analytes were quantified by comparison with known amounts of standards. The % recovery of each standard was used to normalize the data. Detailed information, along with a chromatogram, was reported previously [41] . The individual dose-response plots of Resv and NAcCys on methoxy conjugate, quinone conjugate and DNA adduct levels showed that the dose-response curves were not consistently parallel, indicating more complex relationships. Therefore, we tested for independence and synergism/antagonism using the Bliss equations.
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Non-linear regression was used to model dose-response, and independence or synergism/antagonism was tested using Bliss models [46] . The dose pairs were grouped into four categories as follows: (1) We used these three models to examine the relationship of each agent, and the combination of agents, on methoxy conjugate, quinone conjugate and DNA adduct levels.
The models allow quantification of antagonism/additivity or synergism with a statistical test of significance for model fit. All analyses were done in SAS v. 9.2 (SAS Institute, Cary, NC).
Results and Discussion

NAcCys and/or Resv reverses 4-OHE 2 toxicity in MCF-10F cells
In this study, we examined the cytotoxic effect of 4-OHE 2 on MCF-10F cells using the MTT assay. We observed some cytotoxicity in MCF-10F cells exposed to 10 and/or Resv (0.37-36 μM) and examined viable cells for 0-72 h (Fig. 2) .
The results indicate that NAcCys can protect cells from the cytotoxic effects of 4-OHE 2 ( Fig. 2A) . For example, the addition of NAcCys increased the number of viable
MCF-10F cells treated with 10 μM 4-OHE 2 by 24% after 72 h (66% to 90%).
Interestingly, 10 µM NAcCys abolished the toxic effect of 4-OHE 2 at 24, 48 and 72 h.
Higher doses of NAcCys (15-60 μM) did not just overcome the toxicity of 4-OHE 2 , but promoted cell growth to higher levels than in the untreated control cultures (e.g. at 72 h, 110-129% viable cells, Fig. 2A ). Statistically significant differences were noted by both dose and time point (all p-values < 0.0001), indicating that increasing concentrations of NAcCys improved cell viability at increasing time points.
The incubations with Resv showed that this compound is slightly more effective than NAcCys and even the lowest dose of Resv (0.37 μM) completely eliminated the cytotoxic insult from 10 μM 4-OHE 2 in 72 h (Fig. 2B) . The protective effect of Resv against 4-OHE 2 was more prominent as the dose increased. Similar data were observed when both compounds (NAcCys and Resv) were combined (Fig. 2C) . Therefore, the two antioxidants were not cytotoxic, but protected the cells.
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Inhibition of estrogen-DNA adduct formation by Resv and NAcCys
In our experiments with MCF-10F cells, we divided the metabolic products of 4- Under our experimental conditions, we observed that after treatment, free 4-OHE 2 was undetectable. A major portion was converted to the methoxy conjugate [4-OCH 3 E 1 (E 2 )] by the abundant presence of COMT in the cells [23, 24] , and the remaining catechols were oxidized to form the E 1 (E 2 )-3,4-Q.
The quinones have three major fates ( Fig. 1) : they can be reduced by quinone reductase (NQO1 or NQO2) [25] [26] [27] back to catechols, which can again be methylated by COMT or reoxidized to quinones. Second, the quinones can react with endogenous GSH to form GSH conjugates. Third, the quinones can react with DNA to form estrogen-DNA adducts. Treatment of cells with 10 µM 4-OHE 2 alone showed the expected result (Figs.
3-5), i.e., the formation of methoxy and quinone conjugates, as well as depurinating estrogen-DNA adducts. Fig. 3) . A similar effect was observed with 6 µM Resv, where the methoxy conjugate level increased 42%, corresponding to 305 ± 14 pmole/million cells. On the other hand, when both antioxidant compounds were added together, this effect was greater and the methoxy conjugate level increased 79%. Thus, the level of methoxy compounds increased with higher ratios of antioxidants either alone or mixed together. At the highest dose, in which NAcCys was at a ratio of 1:6 and Resv at 1:3.6 with respect to 4-OHE 2 , the methoxy conjugates were greater with Resv (381% increase), while with NAcCys the increase was 298%. With the mixture, the increase was 1025%, which is three-fold more than the individual antioxidant compounds themselves (Fig. 3) . This result may be explained with the observation from previous experiments that NAcCys and Resv reduce estrogen semiquinones produced in these cells during the oxidation of 4-OHE 2 back to the catechols [16, 28, 47] . The large amount of COMT in the cells assures that the 4-OHE 2 is converted to 4-OCH 3 E 1 (E 2 ) [23, 24] .
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
Therefore, Resv was more effective in increasing the amount of 4-OCH 3 E 1 (E 2 ) than NAcCys. However, attempts at non-linear modeling of the methoxy conjugate doseresponse curve resulted in non-convergent models due to non-singular Hessian matrices.
Therefore statistical tests for antagonism, additivity or synergism could not be conducted.
13
Quinone conjugates. Interesting results were observed for the quinone conjugates, which increased with higher doses of NAcCys (Fig. 4) . At the highest dose, this increase was approximately 2-fold. This is understandable, as NAcCys can react directly with the catechol quinones to form 4-OHE 1 (E 2 )-2-NAcCys [43] . Similarly, NAcCys is a precursor of GSH, which in turn reacts itself with E 1 (E 2 )-3,4-Q to form GSH conjugates.
These convert by the mercapturic acid pathway to 4-OHE 1 (E 2 )-2-Cys and 4-OHE 1 (E 2 )-2-NAcCys (Fig. 1) . On the other hand, Resv did not show any effect on the formation of quinone conjugates at low doses, while at the two highest doses (18 and 36 µM), the quinone conjugate level decreased noticeably (Fig. 4) . The Resv effect on quinone conjugates can be explained by our previous finding that Resv does not react with E 2 -3,4-Q to form any conjugated compound [28] . On the other hand, Resv shows stronger potential in reducing the semiquinone to catechol than NAcCys, and it also induces the enzyme NQO1, which reduces the quinone back to catechol [16, 25, 28, 40] . These processes all reduce the level of quinones available to form conjugates. In the experiments in which both antioxidants were used together, the conjugate level is moderately increased, but at all the selected doses the level reflects the contribution of NAcCys (Fig. 4) .
Looking at Figure (95% confidence interval 0.87-2.02), which being slightly greater than unity, showed that at the higher doses there was evidence of synergism, but the result was not statistically significant. However, the Bliss independence model was found to be independent of the ν parameter and a better fit was found after it was dropped from the model, suggesting
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15 that overall Resv and NAcCys were acting in an additive fashion on methoxy conjugates, quinone conjugates and DNA adduct formation.
In summary, inhibition of estrogen-DNA adduct formation was similar at lower doses of NAcCys and Resv, but at higher doses the effect of Resv was about 50% greater than that of NAcCys.
The depurinating estrogen-DNA adduct levels are considered to be the starting point that generates mutations that lead to breast cancer. These two antioxidants (NAcCys and Resv) may be useful for probing the link between the oxidative metabolism of estrogens and the initiation of cancer.
Conclusion
Estrogen metabolism is characterized by two major pathways. The first one is the 16α-hydroxylation, and the second is the formation of catechols by hydroxylation of the 2-and 4-position [1,2]. 16α-Hydroxylation is not involved in any specific reaction with DNA, whereas oxidation of 2-and 4-catechols leads to their respective quinones, which can react with DNA. The most effective reaction of these quinones with DNA occurs when the 3,4-quinones are formed. In this case, a very effective protonated 1,4-Michael addition [46] leads to the predominant formation (99%) of depurinating estrogen-DNA adducts [6, 7] . Several lines of evidence indicate that this reaction with DNA to form predominantly the depurinating N3Ade and N7Gua adducts could initiate the series of events that lead to the development of cancer [21] . This reaction with DNA occurs more efficiently when the metabolism of estrogens is unbalanced, namely, excessive formation of quinones, which may react with DNA, occurs. The reaction of catechol estrogen
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16 quinones with DNA can be minimized by the specific antioxidants NAcCys and Resv.
NAcCys exerts its protective effects chemically. In fact, NAcCys reacts directly with the catechol estrogen quinones, and is hydrolyzed to Cys, which is used in the biosynthesis of the cellular antioxidant GSH (Fig. 1) . In addition, NAcCys reduces estrogen semiquinones to catechols (Fig. 1) , thereby decreasing the amount of quinones formed.
The reduction of semiquinones to catechols is also obtained with Resv [16, 40] . Resv, however, also exerts enzymatic protective effects, namely, induction of NQO1, which reduces the quinones to catechols (Fig. 2) , and it modulates the expression of CYP1B1, which specifically metabolizes E 2 to 4-OHE 2 ( Fig. 1 ). In conclusion, these two antioxidants provide an excellent combination to minimize the metabolism of estrogens from catechols to catechol quinones. Through these effects, the combination of NAcCys and Resv is expected to inhibit the initiation of cancer by estrogens. 
